Relapsed and Refractory CLL with Javier Pinilla-lbarz, MD, PhD and Paul Barr, MD: Case 1

EP. 1: Javier Pinilla-Ibarz, MD, PhD: Principle Treatment Options for Patients With a 17p Deletion

September 25th 2015

EP. 2: Javier Pinilla-Ibarz, MD, PhD: Additional Chemo-Immunotherapy

September 25th 2015

EP. 3: Javier Pinilla-Ibarz, MD, PhD: Use of Bruton's Tyrosine Kinase Inhibitor

September 25th 2015

EP. 4: Javier Pinilla-Ibarz, MD, PhD: Dose Intensity

September 25th 2015

EP. 5: Javier Pinilla-Ibarz, MD, PhD: Significance of Treating to Progression

September 25th 2015

EP. 6: Paul Barr, MD: Principle Treatment Options for Patients With a 17p Deletion

September 25th 2015

EP. 7: Paul Barr, MD: Additional Chemo-Immunotherapy

September 25th 2015

EP. 8: Paul Barr, MD: Dose Intensity

September 25th 2015

EP. 9: Paul Barr, MD: Significance of Treating to Progression

September 25th 2015